grade
pharmaceutical primary standard
vapor density
2.1 (vs air)
vapor pressure
10 mmHg ( 147 °C), 14.9 mmHg ( 20 °C)
autoignition temp.
700 °F
expl. lim.
13.7 %
manufacturer/tradename
USP
refractive index
n20/D 1.384 (lit.)
bp
97 °C (lit.)
mp
−127 °C (lit.)
density
0.804 g/mL at 25 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CCCO
InChI
1S/C3H8O/c1-2-3-4/h4H,2-3H2,1H3
InChI key
BDERNNFJNOPAEC-UHFFFAOYSA-N
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
1-Propanol USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under 1-丙醇
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Flam. Liq. 2 - STOT SE 3
target_organs
Central nervous system
存储类别
3 - Flammable liquids
flash_point_f
71.6 °F - closed cup
flash_point_c
22 °C - closed cup
法规信息
危险化学品
此项目有
Sailyn Alfonso et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(14), 3660-3671 (2014-05-03)
Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of efficacy and safety of racotumomab as switch maintenance for patients with advanced non-small cell lung cancer (NSCLC). Patients with
Dipankar Bhattacharya et al.
The Journal of general virology, 95(Pt 2), 363-372 (2013-09-03)
Non-structural 5A protein (NS5A) has emerged as an important pharmacological target for hepatitis C virus (HCV). However, little is known about the conformation of NS5A intracellularly or how NS5A inhibitors achieve the picomolar (pM) inhibition of virus replication. Here, we
Zak Perold et al.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 17(2), 190-206 (2014-06-18)
Pyrimethamine, an anti-malarial agent known to exhibit solid state polymorphism, may be purified by means of recrystallization. Recrystallization may alter the solid state chemistry of pharmaceuticals, which may impact the toxicity and/or manufacturability thereof. We evaluated the risks associated with
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 1570406-3AMP | 04061838743084 |
| 1570406-3X1.2ML | 04065271209206 |